Bonk (NASDAQ:BNKK) Trading 42.4% Higher – Should You Buy?

Bonk, Inc. (NASDAQ:BNKK)’s stock price rose 42.4% during mid-day trading on Thursday . The company traded as high as $5.05 and last traded at $3.96. Approximately 74,537,372 shares changed hands during trading, an increase of 46,571% from the average daily volume of 159,708 shares. The stock had previously closed at $2.78.

Analyst Upgrades and Downgrades

BNKK has been the subject of a number of recent analyst reports. Weiss Ratings reissued a “sell (d-)” rating on shares of Bonk in a research report on Monday, December 29th. Wall Street Zen raised shares of Bonk to a “sell” rating in a research report on Saturday, December 13th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, Bonk presently has a consensus rating of “Sell”.

Bonk Price Performance

The firm has a 50 day simple moving average of $4.47. The company has a market cap of $18.46 million, a PE ratio of -0.46 and a beta of 1.90.

Bonk (NASDAQ:BNKK) last announced its quarterly earnings data on Wednesday, November 19th. The company reported ($3.85) earnings per share (EPS) for the quarter. The company had revenue of $1.51 million during the quarter.

About Bonk

Safety Shot, Inc, a wellness and functional beverage company, engages in the research and development of over-the-counter products and intellectual property. Its products pipeline includes Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women’s sexual wellness; NoStingz, a jellyfish sting prevention sunscreen; and JW-110 for the treatment of atopic dermatitis/eczema. The company primarily sell its products through third-party physical retail stores and partners. The company was formerly known as Jupiter Wellness, Inc and changed its name to Safety Shot, Inc in September 2023.